跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
BY-686
首页
药物
BY-686
BY-686
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Method of estimating the risk of expression of adverse drug reaction caused by the administration of a compound, which is either metabolized per se by UGT1A1 enzyme or whose metabolic intermediate is metabolized by the enzyme
US 2007082357 A1
申请人: DAIICHI PURE CHEMICALS CO LTD
优先权: 2000
US
4 件公开
Hyaluronic acid-based zwitterionic polymer brush, preparation method thereof, and use thereof
US 12297300 B2
申请人: UNIV SOUTH CHINA TECH
优先权: 2018
US
Method for creating low-cadmium rice
CN 120350053 A
申请人: INST GENETICS & DEVELOPMENTAL BIOLOGY CAS
优先权: 2024
CN
药物
反馈